Bumper Offer - Urjas oil Just @ Rs. 1
Daprica M Tablet is an allopathic medicine The correct dosage of Daprica M Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Daprica M Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Daprica M Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Daprica M Tablet safe for pregnant women?
Daprica M Tablet has many dangerous side effects in pregnant women. If you are pregnant, do not consume Daprica M Tablet without medical advice.
Is the use of Daprica M Tablet safe during breastfeeding?
In the absence of any scientific study about the side effects of Daprica M Tablet in breastfeeding women, information on safety of Daprica M Tablet is unavailable.
What is the effect of Daprica M Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Daprica M Tablet. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Daprica M Tablet on the Liver?
There may be an adverse effect on the liver after taking Daprica M Tablet. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Daprica M Tablet on the Heart?
Side effects of Daprica M Tablet on heart are unknown because research on this has not been conducted yet.
Daprica M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Daprica M Tablet unless your doctor advises you to do so -
Is this Daprica M Tablet habit forming or addictive?
No, you will not get addicted to Daprica M Tablet .
Interaction between Food and Daprica M Tablet
There is no information on the effects of taking Daprica M Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Daprica M Tablet
Consuming Daprica M Tablet with alcohol can have many serious effects on your body.
Daprica M Tablet works by decreasing the hepatic glucose production. It also works to lower blood sugar by increasing your sensitivity to insulin and decreasing the amount of glucose that is absorbed from the food you eat.
Yes, Daprica M Tablet can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Daprica M Tablet causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Daprica M Tablet may need to be adjusted.
Daprica M Tablet is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Daprica M Tablet increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
Daprica M Tablet is not a known cause of alopecia (hair loss). However, the conditions treated by Daprica M Tablet type 2 diabetes and PCOS, often list hair loss as a possible symptom.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278